CompletedNCT00485550
Official study titleA Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride Augmented With Either Extended-Release Methylphenidate Hydrochloride (Concerta-TM) or Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Not Responded to Stimulant Mono Therapy
This study has finished and is no longer accepting participants.
In ScottsdaleADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Eli Lilly and Company
CompletedNCT00406354
Official study titleA Randomized, Double-Blind Comparison of Atomoxetine Versus Placebo in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BerlinADHDMedication studyAges 6–17
- Countries
- Germany
- Sponsor
- Eli Lilly and Company
CompletedNCT00546910
Official study titleA Randomized, Double Blind Comparison of the Effects of Atomoxetine Versus Placebo on Neuropsychological Outcomes Across the Day in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) by Use of a Computer Based Continuous Performance Test (cb CPT)
This study has finished and is no longer accepting participants.
Multiple locations, including BerlinADHDMedication studyAges 6–12
- Countries
- Germany
- Sponsor
- Eli Lilly and Company
CompletedNCT00711724
Official study titleComparison of Self and Clinician Administered Rating Scales in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In CambridgeADHDObservational studyAges 13–18
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00760747
What is this study about?Researchers studied atomoxetine to find out how it affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including MiltonADHDMedication studyAges 6–16
- Countries
- Australia, United Kingdom, Mexico
- Sponsor
- Eli Lilly and Company
CompletedNCT01065259
Official study titleRandomized Control Study of Concerta and Strattera on the Improvement of Executive Function in Attention Deficit Hyperactivity Disorder Children
This study has finished and is no longer accepting participants.
In BeijingADHDMedication studyAges 6–16
- Countries
- China
- Sponsor
- Peking University
WithdrawnNCT01118650
Official study titleConcordance of the Quotient ADHD System Report With Teacher and Parent Assessments in School-Aged Children Receiving an Individualized Education Program (IEP) or 504 Accommodations in the Classroom Setting for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD)
This study was withdrawn before enrollment.
Location not clearly listedADHDObservational studyAges 8–14
- Countries
- Sponsor
- BioBehavioral Diagnostics Company
CompletedNCT01705613
This study has finished and is no longer accepting participants.
In Porto AlegreADHDObservational studyAges 6–18
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre
CompletedNCT01228604
This study has finished and is no longer accepting participants.
In Porto AlegreADHDMedication studyAges 8–10
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre
CompletedNCT02457819
What is this study about?Researchers studied Dasotraline, tracking side effects to assess safety in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT00434928
Official study titleDietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In VancouverADHDObservational studyAges 6–12
- Countries
- Canada
- Sponsor
- University of British Columbia
CompletedNCT00315276
What is this study about?This study evaluated the safety and effectiveness of Modafinil for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Cephalon
